Recently, Lombardo et al. showed that ALK mutations (and ALK activation) could regulate PD-L1 expression in neuroblastoma cell models using a computational approach predicting potential intracellular events/factors that may influence PD-L1 expression in cancer. Here, ALK is linked to cancer.